About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1473 record(s)
Req # A-2021-001081
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106965-484.Organization: Health Canada
January 2022
Req # A-2021-001085
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-107359-473.Organization: Health Canada
January 2022
Req # A-2021-001112
Adverse Drug Reactions (ADRs) for ISENTRESS. Report numbers: E2B_02411753, E2B_02476798, E2B_02494149, E2B_02496852. ADRs for JANUMET. Report numbers: 000517814, E2B_02205613, E2B_02309078, 000514063, 000527263, 000527937.Organization: Health Canada
January 2022
Req # A-2021-001116
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_00122784, 000945885, E2B_03841580.Organization: Health Canada
January 2022
Req # A-2021-001122
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03789023, E2B_03605750, E2B_03978565, E2B_04078040.Organization: Health Canada
January 2022
Req # A-2021-001132
Adverse Drug Reactions (ADRs) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_03524636, E2B_03948459, E2B_03594125, 948608, E2B_03535719, E2B_03992693, E2B_04010997, E2B_03716535.Organization: Health Canada
January 2022
Req # A-2021-001135
Adverse Drug Reactions (ADRs) for HYOSCINE BUTYLBROMIDE. Report numbers: 949293, 000940500, 936544, 943443.Organization: Health Canada
January 2022
Req # A-2021-001141
Adverse Drug Reactions (ADRs) for INSULIN GLARGINE. Report numbers: E2B_03749706, E2B_03927923, 000930023, E2B_03837648, E2B_03851710, E2B_04009738, E2B_04011324, E2B_03837029, E2B_03788494.Organization: Health Canada
January 2022
Req # A-2021-001154
Adverse Drug Reactions (ADRs) for BISACODYL. Report numbers: E2B_04088726, E2B_03710741, E2B_03652169, E2B_03866608, 942095, 943689, E2B_03898087.Organization: Health Canada
January 2022
Req # A-2021-001155
Adverse Drug Reactions (ADRs) for CABAZITAXEL. Report numbers: E2B_03828775, E2B_03946636.Organization: Health Canada
January 2022